The first half of 2026 has already seen plenty of leadership changes as medical device companies look to shake up their C-suites or reshape their organizational structure.
Hologic named José Almeida as CEO following its $18.3 billion go-private deal, and Edwards Lifesciences and BD appointed new CFOs.
DePuy Synthes, Johnson & Johnson’s orthopedics unit, also named a CFO. Christina Zamarro will take over the post ahead of a planned spinoff that will see DePuy Synthes operate as a standalone firm.
Medtronic announced that Eric Lenard, who spent more than 20 years at J&J, will become the vice president and CFO for innovation, development and quality. When the hire was announced, CFO Thierry Piéton said the newly created role “brings Finance even closer to how we prioritize, fund, and execute R&D at enterprise scale.”
Elsewhere, Insulet named its first chief research and development officer, and Illumina appointed a chief commercial officer and a chief legal officer.
Read on for more about key executive moves MedTech Dive has followed in 2026:
